Related Experiment Video
Updated: Oct 3, 2026

Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling
Published on: March 20, 2018
Metabolism of genotoxic agents: halogenated compounds
Abstract:
Most halogenated compounds showing genotoxicity do not themselves react with macromolecules but are transformed to reactive metabolites. In order to explain the widely different genotoxicities of halogenated ethylenes, the 'optimum stability' theory of epoxides has been developed recently. An epoxide must be reactive to alkylate DNA, but stable enough to reach the target from the place of its formation. Also, pharmacokinetic aspects are important in accounting for differences in genotoxicities of closely related compounds; examples are provided. Reactive metabolites may bind to proteins, to lipids and coenzymes, and to DNA, but binding to targets other than DNA is far more common than DNA alkylation. An example is provided by investigations on 2,2'-dichlorodiethyl ether from which chloroacetaldehyde is formed. In contrast to vinyl chloride, which generates chloroethylene oxide (chlorooxirane) as well as chloroacetaldehyde, this compound leads to extensive covalent protein binding of metabolites, but not to DNA binding.
More Related Videos
Related Concept Videos
Mutagenicity and Carcinogenicity
Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Bioactivation and Tissue Toxicity
Spontaneous and Induced Mutations

